AIFA intends to acquire expressions of interest from public University Institutions for the establishment of a two-year collaboration relationship, within the framework of the Joint Actions contained in the Work Plan (WP) 2022 of the Programme for European Union action in the field of health for the period 2021-2027 (EU4Health).

The selected University Institution will be called upon to collaborate with the Agency to identify the most appropriate actions to avoid duplication of work and disharmonisation of assessments among the National Competent Authorities, with reference to bioequivalence studies submitted in support of Marketing Authorisation (MA) applications for medicinal products for human use, in the framework of decentralised/mutual recognition and national MA procedures.